Home Business & Finance Novo Nordisk sues Eli Lilly over ads comparing GLP-1 medications
Business & Finance

Novo Nordisk sues Eli Lilly over ads comparing GLP-1 medications

Novo Nordisk sues Eli Lilly over ads comparing GLP-1 medications
Key Points

The Danish company Novo says U.S.-based Lilly isn’t including the most up-to-date clinical information about its drugs.

The Danish company Novo says U.S.-based Lilly isn’t including the most up-to-date clinical information about its drugs. [Image text:] novo nordisk
Novo Nordisk (ORG) Eli Lilly (ORG) Danish (ORG) Novo (ORG) Lilly (ORG)
Originally published by MarketWatch Read original →